The company offers formulations across therapeutic areas, such as cardiovascular, gastrointestinal, analgesics, haematinics, anti-infectives and antibiotics, respiratory agents, antidiabetics and immunologicals.
2.
It also seems likely from the absence of follow-up papers since 2001 that the " haematinic effect " has not been reproducible in people, but I might be wrong of course and some major drug company may be in the secretive phase of investigating a potentially profitable protein . alteripse 11 : 46, 27 October 2005 ( UTC)
मोबाइल